Through new partnerships with industry leaders, Nvidia aims to help advance practical use cases for AI in healthcare and life ...

Astellas is shifting its investment focus toward more established modalities and later-stage opportunities, its chief ...

Market OverviewThe Global Carrier Screening Market is a genetic testing process that determines whether an individual carries ...

China has put Illumina on its ‘unreliable entity list’ after the US imposed sanctions on Beijing Genomics Institute, also a ...

Illumina, Inc. (NASDAQ:ILMN – Get Free Report)’s share price reached a new 52-week low during mid-day trading on Wednesday after Morgan Stanley lowered their price target on the stock from $150.00 to ...

Beijing’s action against clothing maker PVH and biotech company Illumina underlines risk created by trade tensions ...

Shares of gene-sequencing leader Illumina have fallen 15% from Friday. Rivals 10X Genomics and Pacific BioSciences of ...

North America transcriptomics market is projected to grow by 10.3% annually in the forecast period and reach $6,124.0 million by 2031, driven by the surging demand for personalize ...

Precision medicine is an innovative approach in healthcare that takes into account individual differences in genes, ...

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

The top opportunities in the genomic data analysis and interpretation market segmented by end-user will arise in the pharmaceutical and biotechnology companies segment, which will gain $756.71 million ...

Jeff Bezos has come a long way in the past 30 years — as has the company he founded in 1994, Amazon.com Inc. (ticker: AMZN). Amazon ranks as the No. 2 company in the world by ...